NASDAQ:KTOV - KITOV PHARMA LT/S News Headlines

Sign in or create an account to add this stock to your watchlist.
$1.18 -0.04 (-3.28 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$1.22
Today's Range$1.13 - $1.24
52-Week Range$0.56 - $3.81
Volume325,151 shs
Average Volume2.49 million shs
Market Capitalization$18.59 million
P/E Ratio3.00
Dividend YieldN/A
Beta4.39

Headlines

KITOV PHARMA LT/S (NASDAQ KTOV) News Headlines

Source:
DateHeadline
Potential Milestones Coming for Kitov Pharma and Product Commercialization PlansPotential Milestones Coming for Kitov Pharma and Product Commercialization Plans
finance.yahoo.com - March 18 at 9:33 AM
Kitov to Acquire Clinical Stage Candidate CM-24 Creating a Transformational Immuno-Oncology CompanyKitov to Acquire Clinical Stage Candidate CM-24 Creating a Transformational Immuno-Oncology Company
finance.yahoo.com - March 14 at 10:27 AM
Kitov Pharma Reports Year End 2018 Financial Results and Provides Business UpdateKitov Pharma Reports Year End 2018 Financial Results and Provides Business Update
finance.yahoo.com - February 7 at 9:47 AM
Form 6-K Kitov Pharma Ltd. For: Jan 18 - StreetInsider.comForm 6-K Kitov Pharma Ltd. For: Jan 18 - StreetInsider.com
www.streetinsider.com - January 20 at 5:29 PM
Kitov Updates Investors On NT-219 And Sends The Stock Parabolic, I Provide Reasons For Investors To HoldKitov Updates Investors On NT-219 And Sends The Stock Parabolic, I Provide Reasons For Investors To Hold
seekingalpha.com - January 18 at 8:09 PM
Kitov Closes $6 Million Registered Direct OfferingKitov Closes $6 Million Registered Direct Offering
finance.yahoo.com - January 18 at 8:09 PM
New Data on Kitovs NT219 Demonstrates its Unique Mechanism of Action and Anti-Cancer Effect - GlobeNewswireNew Data on Kitov's NT219 Demonstrates its Unique Mechanism of Action and Anti-Cancer Effect - GlobeNewswire
globenewswire.com - January 17 at 5:02 PM
Form SC 13G Kitov Pharma Ltd. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.comForm SC 13G Kitov Pharma Ltd. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.com
www.streetinsider.com - January 17 at 5:02 PM
Kitov Pharmas Stock Up on Anti-Cancer Candidate FindingsKitov Pharma's Stock Up on Anti-Cancer Candidate Findings
www.zacks.com - January 16 at 4:52 PM
4 Healthcare Stocks Seeing Gains On Wednesday (1/16/19)4 Healthcare Stocks Seeing Gains On Wednesday (1/16/19)
finance.yahoo.com - January 16 at 4:52 PM
Kitov Announces Pricing of $6 Million Registered Direct OfferingKitov Announces Pricing of $6 Million Registered Direct Offering
finance.yahoo.com - January 16 at 4:52 PM
Thinking about buying stock in Aurora Cannabis Inc, Goodyear Tire & Rubber, Kitov Pharma, PG&E Corp or VirnetX?Thinking about buying stock in Aurora Cannabis Inc, Goodyear Tire & Rubber, Kitov Pharma, PG&E Corp or VirnetX?
www.marketwatch.com - January 16 at 9:40 AM
SSYS, ARRY among premarket gainersSSYS, ARRY among premarket gainers
seekingalpha.com - January 15 at 9:38 AM
New Data on Kitov’s NT219 Demonstrates its Unique Mechanism of Action and Anti-Cancer EffectNew Data on Kitov’s NT219 Demonstrates its Unique Mechanism of Action and Anti-Cancer Effect
finance.yahoo.com - January 15 at 9:38 AM
Kitov Secures Consensi Commercial Deal With CoeptisKitov Secures Consensi Commercial Deal With Coeptis
seekingalpha.com - January 7 at 5:10 PM
Kitov +40% on signing marketing agreement with Coeptis Pharmaceuticals for ConsensiKitov +40% on signing marketing agreement with Coeptis Pharmaceuticals for Consensi
seekingalpha.com - January 3 at 9:52 AM
Kitov Signs Marketing and Distribution Agreement for its Lead Product Consensi™ in the U.S. with Coeptis PharmaceuticalsKitov Signs Marketing and Distribution Agreement for its Lead Product Consensi™ in the U.S. with Coeptis Pharmaceuticals
finance.yahoo.com - January 3 at 9:52 AM
4 Healthcare Stocks Gaining Speed on Thursday (1/3/19)4 Healthcare Stocks Gaining Speed on Thursday (1/3/19)
finance.yahoo.com - January 3 at 9:52 AM
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of American Depository Shares and Warrants of Kitov Pharmaceuticals Holdings, Ltd. -- KTOVPomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of American Depository Shares and Warrants of Kitov Pharmaceuticals Holdings, Ltd. -- KTOV
finance.yahoo.com - October 15 at 9:19 AM
Kitov Appoints Gil Efron as Deputy Chief Executive Officer and Chief Financial OfficerKitov Appoints Gil Efron as Deputy Chief Executive Officer and Chief Financial Officer
finance.yahoo.com - October 11 at 9:12 AM
Kitov to Present Data on NT219 in Combination with Keytruda® and Erbitux® at AACR International Cancer Immunotherapy ConferenceKitov to Present Data on NT219 in Combination with Keytruda® and Erbitux® at AACR International Cancer Immunotherapy Conference
finance.yahoo.com - September 26 at 9:51 AM
Kitov Pharma Updates on Motions in USA Initiated by Kitov ChairmanKitov Pharma Updates on Motions in USA Initiated by Kitov Chairman
finance.yahoo.com - September 18 at 4:11 PM
Kitov Pharma Provides Corporate Update and Reports First Half 2018 Financial ResultsKitov Pharma Provides Corporate Update and Reports First Half 2018 Financial Results
finance.yahoo.com - August 29 at 9:56 AM
Kitov Announces Settlement of Shareholder Class Action LitigationKitov Announces Settlement of Shareholder Class Action Litigation
finance.yahoo.com - July 30 at 4:11 PM
Kitov to Host Business Update Conference Call on Monday, July 2Kitov to Host Business Update Conference Call on Monday, July 2
finance.yahoo.com - June 27 at 11:49 AM
Kitov Announces Positive Pre-clinical Data from NT219 Demonstrating its Dose-Dependent Anti-Tumor EfficacyKitov Announces Positive Pre-clinical Data from NT219 Demonstrating its Dose-Dependent Anti-Tumor Efficacy
finance.yahoo.com - June 26 at 11:27 AM
Kitov Pharma (KTOV) Reports Positive Pre-clinical Data from NT219 Demonstrating its Dose-Dependent Anti-Tumor EfficacyKitov Pharma (KTOV) Reports Positive Pre-clinical Data from NT219 Demonstrating its Dose-Dependent Anti-Tumor Efficacy
www.streetinsider.com - June 16 at 8:51 AM
The FDA Just Approved Kitovs Consensi - Now What?The FDA Just Approved Kitov's Consensi - Now What?
seekingalpha.com - June 11 at 4:20 PM
Mid-Afternoon Market Update: Crude Oil Down 1.5%; Euro Tech Holdings Shares Spike HigherMid-Afternoon Market Update: Crude Oil Down 1.5%; Euro Tech Holdings Shares Spike Higher
www.benzinga.com - June 1 at 4:14 PM
Mid-Day Market Update: Lululemon Surges After Strong Q1 Results; Kitov Pharma Shares PlungeMid-Day Market Update: Lululemon Surges After Strong Q1 Results; Kitov Pharma Shares Plunge
www.nasdaq.com - June 1 at 4:14 PM
Your Daily Pharma Scoop: Madrigal Zooms Ahead, Kitov Gets Approval, MEI Pharmas Results Are PositiveYour Daily Pharma Scoop: Madrigal Zooms Ahead, Kitov Gets Approval, MEI Pharma's Results Are Positive
seekingalpha.com - June 1 at 4:14 PM
Kitov Pharma (KTOV) Announces FDA Approval for ConsensiKitov Pharma (KTOV) Announces FDA Approval for Consensi
www.streetinsider.com - June 1 at 9:45 AM
Kitov Announces Pricing of $8,150,000 Registered Direct OfferingKitov Announces Pricing of $8,150,000 Registered Direct Offering
finance.yahoo.com - June 1 at 9:45 AM
FDA Approves Kitov’s Consensi™ for Treatment of Osteoarthritis Pain and HypertensionFDA Approves Kitov’s Consensi™ for Treatment of Osteoarthritis Pain and Hypertension
finance.yahoo.com - May 31 at 4:18 PM
Kitov Pharma up 12% premarket ahead of FDA decision on KIT-302Kitov Pharma up 12% premarket ahead of FDA decision on KIT-302
seekingalpha.com - May 31 at 9:58 AM
Kitov down 13% ahead of FDA action date on KIT-302Kitov down 13% ahead of FDA action date on KIT-302
seekingalpha.com - May 22 at 4:14 PM
Week In Review: Fosun In $2 Billion Bidding War For U.S. Rights To Novartis Generic DrugsWeek In Review: Fosun In $2 Billion Bidding War For U.S. Rights To Novartis' Generic Drugs
seekingalpha.com - May 20 at 9:56 AM
Wired News – Kitov Pharma Signs Consensi(TM) Commercialization Deal with Changshan Pharma in ChinaWired News – Kitov Pharma Signs Consensi(TM) Commercialization Deal with Changshan Pharma in China
finance.yahoo.com - May 15 at 10:20 AM
Kitov Pharma (KTOV) Reports Consensi Commercialization Agreement for ChinaKitov Pharma (KTOV) Reports Consensi Commercialization Agreement for China
www.streetinsider.com - May 11 at 10:44 AM
Kitov Announces Consensi™ Commercialization Agreement for ChinaKitov Announces Consensi™ Commercialization Agreement for China
finance.yahoo.com - May 11 at 10:44 AM
TyrNovo to Present at 2018 Annual Meeting of the American Association for Cancer ResearchTyrNovo to Present at 2018 Annual Meeting of the American Association for Cancer Research
finance.yahoo.com - April 13 at 10:10 AM
Kitov Pharmaceuticals Publishes Annual Report for 2017 and Issues CEO Letter to ShareholdersKitov Pharmaceuticals Publishes Annual Report for 2017 and Issues CEO Letter to Shareholders
finance.yahoo.com - March 5 at 10:01 AM
Kitov Announces Consensi™ as Brand Name for KIT-302Kitov Announces Consensi™ as Brand Name for KIT-302
finance.yahoo.com - December 14 at 6:06 PM
BRIEF-Kitov pharmaceuticals announces receipt of FDAs favorable response to NT219s pre-ind meeting packageBRIEF-Kitov pharmaceuticals announces receipt of FDA's favorable response to NT219's pre-ind meeting package
www.reuters.com - November 3 at 6:50 PM
Kitov Pharmaceuticals Announces Receipt of FDAs Favorable Response to NT219s pre-IND Meeting PackageKitov Pharmaceuticals Announces Receipt of FDA's Favorable Response to NT219's pre-IND Meeting Package
finance.yahoo.com - November 2 at 4:47 AM
Kitov Pharmaceuticals: An UpdateKitov Pharmaceuticals: An Update
seekingalpha.com - November 1 at 5:06 AM
Kitov Pharmaceuticals Announces Phase III/IV Clinical Trial for KIT-302 Successfully Meets Primary Endpoint, and also Demonstrates Drug Candidate Improves Renal FunctionKitov Pharmaceuticals Announces Phase III/IV Clinical Trial for KIT-302 Successfully Meets Primary Endpoint, and also Demonstrates Drug Candidate Improves Renal Function
finance.yahoo.com - October 26 at 4:48 PM
BRIEF-Kitov boosts ownership in Tyrnovo and Oncology platformBRIEF-Kitov boosts ownership in Tyrnovo and Oncology platform
www.reuters.com - October 7 at 2:08 AM
Kitov ups stake in oncology-focused TyrNovo to 92%; shares ahead 9% premarketKitov ups stake in oncology-focused TyrNovo to 92%; shares ahead 9% premarket
seekingalpha.com - October 7 at 2:08 AM
Kitov Boosts Ownership in TyrNovo and Oncology Platform Through Exchange of Shares for StockKitov Boosts Ownership in TyrNovo and Oncology Platform Through Exchange of Shares for Stock
finance.yahoo.com - October 7 at 2:08 AM
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel